Skip to main content

Advertisement

Log in

Experimental autoimmune prostatitis: different antigens induction and antigen-specific therapy

  • Urology - Review
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) has uncertain etiology and lacks effective treatment. Autoimmunity is an important pathogeny, and experimental autoimmune prostatitis (EAP) models have long been used for studying CP/CPPS. This review presents the detailed current knowledge of EAP models based on evaluation criteria aspects to provide a tool for model selection in pathogenesis studies and therapeutic drug screening.

Methods

We extensively searched the published literature on CP/CPPS and different antigen-induced EAP models focusing on the histopathology, clinical-related phenotypes, and biochemical indicators. We also cover the changes in the prostate function and other organs in EAP. Finally, we try to get some insights about antigen-based therapeutic approaches for CP/CPPS.

Results

Several inciting autoantigens were reported in EAP, including male accessory gland extracts, prostate extracts (PE), prostatic steroid-binding protein, prostatic spermine-binding protein (p25), prostatic acid phosphatase, seminal vesicle secretory protein 2, and T2 peptide. All of these models mimicked histological prostatitis, however only p25- and T2-induced models developed both pelvic pain and voiding behaviors. PE immunization is the most widely used method. Diminished fertility and mental health disorders can be found in PE model. Oral and intravenous T2 peptide have been studied for antigen-specific therapy and achieved preliminary progress in EAP models.

Conclusions

PE-induced model is the most commonly used, while T2- or p25-model could serve as a promising CP/CPPS model. Antigen-specific therapy in CP/CPPS deserves further study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Penna G, Amuchastegui S, Cossetti C, Aquilano F, Mariani R, Giarratana N, De Carli E, Fibbi B, Adorini L (2007) Spontaneous and prostatic steroid binding protein peptide-induced autoimmune prostatitis in the nonobese diabetic mouse. J Immunol 179(3):1559–1567. https://doi.org/10.4049/jimmunol.179.3.1559

    Article  CAS  PubMed  Google Scholar 

  2. Ye C, Xiao G, Xu J, Qin S, Luo Y, Chen G, Lai HH, Zhou T (2018) Differential expression of immune factor between patients with chronic prostatitis/chronic pelvic pain syndrome and the healthy volunteers. Int Urol Nephrol 50(3):395–399. https://doi.org/10.1007/s11255-017-1763-z

    Article  CAS  PubMed  Google Scholar 

  3. Clemens JQ, Mullins C, Ackerman AL, Bavendam T, van Bokhoven A, Ellingson BM, Harte SE, Kutch JJ, Lai HH, Martucci KT, Moldwin R, Naliboff BD, Pontari MA, Sutcliffe S, Landis JR, Grp MRNS (2019) Urologic chronic pelvic pain syndrome: insights from the MAPP Research Network. Nat Rev Urol 16(3):187–200. https://doi.org/10.1038/s41585-018-0135-5

    Article  PubMed  PubMed Central  Google Scholar 

  4. Liao C-H, Lin H-C, Huang C-Y (2016) Chronic prostatitis/chronic pelvic pain syndrome is associated with irritable bowel syndrome: a population-based study. Sci Rep. https://doi.org/10.1038/srep26939

    Article  PubMed  PubMed Central  Google Scholar 

  5. Farmer MA, Chanda ML, Parks EL, Baliki MN, Apkarian AV, Schaeffer AJ (2011) Brain functional and anatomical changes in chronic prostatitis/chronic pelvic pain syndrome. J Urol 186(1):117–124. https://doi.org/10.1016/j.juro.2011.03.027

    Article  PubMed  PubMed Central  Google Scholar 

  6. Shoskes DA, Prots D, Karns J, Horhn J, Shoskes AC (2011) Greater endothelial dysfunction and arterial stiffness in men with chronic prostatitis/chronic pelvic pain syndrome—a possible link to cardiovascular disease. J Urol 186(3):907–910. https://doi.org/10.1016/j.juro.2011.04.063

    Article  PubMed  Google Scholar 

  7. Clemens JQ, Brown SO, Calhoun EA (2008) Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: a case/control study. J Urol 180(4):1378–1382. https://doi.org/10.1016/j.juro.2008.06.032

    Article  PubMed  PubMed Central  Google Scholar 

  8. Wazir J, Ullah R, Li S, Hossain MA, Diallo MT, Khan FU, Ihsan AU, Zhou X (2019) Efficacy of acupuncture in the treatment of chronic prostatitis-chronic pelvic pain syndrome: a review of the literature. Int Urol Nephrol 51(12):2093–2106. https://doi.org/10.1007/s11255-019-02267-2

    Article  PubMed  Google Scholar 

  9. Hu M, Wazir J, Ullah R, Wang W, Cui X, Tang M, Zhou X (2019) Phytotherapy and physical therapy in the management of chronic prostatitis–chronic pelvic pain syndrome. Int Urol Nephrol 51(7):1081–1088. https://doi.org/10.1007/s11255-019-02161-x

    Article  CAS  PubMed  Google Scholar 

  10. Motrich RD, Maccioni M, Riera CM, Rivero VE (2007) Autoimmune prostatitis: state of the art. Scand J Immunol 66(2–3):217–227. https://doi.org/10.1111/j.1365-3083.2007.01971.x

    Article  CAS  PubMed  Google Scholar 

  11. Dunphy EJ, Eickhoff JC, Muller CH, Berger RE, McNeel DG (2004) Identification of antigen-specific IgG in sera from patients with chronic prostatitis. J Clin Immunol 24(5):492–502. https://doi.org/10.1023/B:JOCI.0000040920.96065.5a

    Article  CAS  PubMed  Google Scholar 

  12. Ponniah S, Arah I, Alexander RB (2000) PSA is a candidate self-antigen in autoimmune chronic prostatitis/chronic pelvic pain syndrome. Prostate 44(1):49–54

    Article  CAS  Google Scholar 

  13. Kouiavskaia DV, Southwood S, Berard CA, Klyushnenkova EN, Alexander RB (2009) T-cell recognition of prostatic peptides in men with chronic prostatitis/chronic pelvic pain syndrome. J Urol 182(5):2483–2489. https://doi.org/10.1016/j.juro.2009.07.067

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Breser ML, Motrich RD, Sanchez LR, Rivero VE (2017) Chronic pelvic pain development and prostate inflammation in strains of mice with different susceptibility to experimental autoimmune prostatitis. Prostate 77(1):94–104. https://doi.org/10.1002/pros.23252

    Article  CAS  PubMed  Google Scholar 

  15. Wang W, Naveed M, Baig MMFA, Abbas M, Zhou X (2018) Experimental rodent models of chronic prostatitis and evaluation criteria. Biomed Pharmacother 108:1894–1901. https://doi.org/10.1016/j.biopha.2018.10.010

    Article  PubMed  Google Scholar 

  16. Alexander RB, Brady F, Ponniah S (1997) Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins. Urology 50(6):893–899. https://doi.org/10.1016/s0090-4295(97)00456-1

    Article  CAS  PubMed  Google Scholar 

  17. Ludwig M, Steltz C, Huwe P, Schaffer R, Altmannsberger M, Weidner W (2001) Immunocytological analysis of leukocyte subpopulations in urine specimens before and after prostatic massage. Eur Urol 39(3):277–282. https://doi.org/10.1159/000052453

    Article  CAS  PubMed  Google Scholar 

  18. Lu JC, Shen JM, Hu XC, Peng LP, Hong ZW, Yao B (2018) Identification and preliminary study of immunogens involved in autoimmune prostatitis in human males. Prostate 78(14):1092–1102. https://doi.org/10.1002/pros.23684

    Article  CAS  Google Scholar 

  19. He L, Wang Y, Long Z, Jiang C (2010) Clinical significance of IL-2, IL-10, and TNF-alpha in prostatic secretion of patients with chronic prostatitis. Urology 75(3):654–657. https://doi.org/10.1016/j.urology.2009.09.061

    Article  PubMed  Google Scholar 

  20. Motrich RD, Maccioni M, Molina R, Tissera A, Olmedo J, Riera CM, Rivero VE (2005a) Presence of INF gamma-secreting lymphocytes specific to prostate antigens in a group of chronic prostatitis patients. Clin Immunol 116(2):149–157. https://doi.org/10.1016/j.clim.2005.03.011

    Article  CAS  PubMed  Google Scholar 

  21. Penna G, Mondaini N, Amuchastegui S, Innocenti SD, Carini M, Giubilei G, Fibbi B, Colli E, Maggi M, Adorini L (2007) Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia. Eur Urol 51(2):524–533. https://doi.org/10.1016/j.eururo.2006.07.016

    Article  CAS  PubMed  Google Scholar 

  22. Desireddi NV, Campbell PL, Stern JA, Sobkoviak R, Chuai S, Shahrara S, Thumbikat P, Pope RM, Landis JR, Koch AE, Schaeffer AJ (2008) Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha as possible biomarkers for the chronic pelvic pain syndrome. J Urol 179(5):1857–1861. https://doi.org/10.1016/j.juro.2008.01.028 (discussion 1861–1852)

    Article  PubMed  PubMed Central  Google Scholar 

  23. Tomaskovic I, Ruzic B, Trnski D, Kraus O (2009) Chronic prostatitis/chronic pelvic pain syndrome in males may be an autoimmune disease, potentially responsive to corticosteroid therapy. Med Hypotheses 72(3):261–262. https://doi.org/10.1016/j.mehy.2008.10.020

    Article  CAS  PubMed  Google Scholar 

  24. Hedelin H, Jonsson K (2007) Chronic abacterial prostatitis and cold exposure: an explorative study. Scand J Urol Nephrol 41(5):430–435. https://doi.org/10.1080/00365590701365123

    Article  PubMed  Google Scholar 

  25. Rudick CN, Berry RE, Johnson JR, Johnston B, Klumpp DJ, Schaeffer AJ, Thumbikat P (2011) Uropathogenic Escherichia coli induces chronic pelvic pain. Infect Immun 79(2):628–635. https://doi.org/10.1128/iai.00910-10

    Article  CAS  PubMed  Google Scholar 

  26. Doble A, Walker MM, Harris JR, Taylor-Robinson D, Witherow RO (1990) Intraprostatic antibody deposition in chronic abacterial prostatitis. Br J Urol 65(6):598–605. https://doi.org/10.1111/j.1464-410X.1990.tb14827.x

    Article  CAS  PubMed  Google Scholar 

  27. Altuntas CZ, Daneshgari F, Veizi E, Izgi K, Bicer F, Ozer A, Grimberg KO, Bakhautdin B, Sakalar C, Tasdemir C, Tuohy VK (2013) A novel murine model of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) induced by immunization with a spermine binding protein (p25) peptide. Am J Physiol Regul Integr Comp Physiol 304(6):R415–R422. https://doi.org/10.1152/ajpregu.00147.2012

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Correa SG, Riera CM, Iribarren P (1997) Involvement of peritoneal dendritic cells in the induction of autoimmune prostatitis. J Autoimmun 10(2):107–113. https://doi.org/10.1006/jaut.1996.0118

    Article  CAS  PubMed  Google Scholar 

  29. Done JD, Rudick CN, Quick ML, Schaeffer AJ, Thumbikat P (2012) Role of mast cells in male chronic pelvic pain. J Urol 187(4):1473–1482. https://doi.org/10.1016/j.juro.2011.11.116

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Roman K, Done JD, Schaeffer AJ, Murphy SF, Thumbikat P (2014) Tryptase-PAR2 axis in experimental autoimmune prostatitis, a model for chronic pelvic pain syndrome. Pain 155(7):1328–1338. https://doi.org/10.1016/j.pain.2014.04.009

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Rudick CN, Schaeffer AJ, Thumbikat P (2008) Experimental autoimmune prostatitis induces chronic pelvic pain. Am J Physiol Regul Integr Comp Physiol 294(4):R1268–R1275. https://doi.org/10.1152/ajpregu.00836.2007

    Article  CAS  PubMed  Google Scholar 

  32. Quick ML, Mukherjee S, Rudick CN, Done JD, Schaeffer AJ, Thumbikat P (2012) CCL2 and CCL3 are essential mediators of pelvic pain in experimental autoimmune prostatitis. Am J Physiol Regul Integr Comp Physiol 303(6):R580–R589. https://doi.org/10.1152/ajpregu.00240.2012

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Motrich RD, van Etten E, Baeke F, Riera CM, Mathieu C, Rivero VE (2010) Crucial role of interferon-gamma in experimental autoimmune prostatitis. J Urol 183(3):1213–1220. https://doi.org/10.1016/j.juro.2009.11.008

    Article  CAS  PubMed  Google Scholar 

  34. Motrich RD, Breser ML, Sanchez LR, Godoy GJ, Prinz I, Rivero VE (2016) IL-17 is not essential for inflammation and chronic pelvic pain development in an experimental model of chronic prostatitis/chronic pelvic pain syndrome. Pain 157(3):585–597. https://doi.org/10.1097/j.pain.0000000000000405

    Article  CAS  PubMed  Google Scholar 

  35. Rivero V, Carnaud C, Riera CM (2002) Prostatein or steroid binding protein (PSBP) induces experimental autoimmune prostatitis (EAP) in NOD mice. Clin Immunol 105(2):176–184. https://doi.org/10.1006/clim.2002.5281

    Article  CAS  PubMed  Google Scholar 

  36. Hou YF, DeVoss J, Dao V, Kwek S, Simko JP, McNeel DG, Anderson MS, Fong L (2009) An aberrant prostate antigen-specific immune response causes prostatitis in mice and is associated with chronic prostatitis in humans. J Clin Investig 119(7):2031–2041. https://doi.org/10.1172/jci38332

    Article  CAS  PubMed  Google Scholar 

  37. Depiante-Depaoli M, Pacheco-Rupil B (1985) Experimental autoimmunity to rat male accessory glands (MAG): circulating antibodies, immunoglobulins bound to target glands, and immunoglobulins-secreting cells. Am J Reprod Immunol Microbiol 7(1):32–38. https://doi.org/10.1111/j.1600-0897.1985.tb00260.x

    Article  CAS  PubMed  Google Scholar 

  38. Fong L, Ruegg CL, Brockstedt D, Engleman EG, Laus R (1997) Induction of tissue-specific autoimmune prostatitis with prostatic acid phosphatase immunization: implications for immunotherapy of prostate cancer. J Immunol 159(7):3113–3117

    CAS  PubMed  Google Scholar 

  39. Qi X, Han L, Liu X, Zhi J, Zhao B, Chen D, Yu F, Zhou X (2012) Prostate extract with aluminum hydroxide injection as a novel animal model for chronic prostatitis/chronic pelvic pain syndrome. Urology 80(6):1389.e1389–1315. https://doi.org/10.1016/j.urology.2012.07.030

    Article  Google Scholar 

  40. Yamaguchi H, Kurita M, Okamoto K, Kotera T, Oka M (2019) Voiding behavior and chronic pelvic pain in two types of rat nonbacterial prostatitis models: attenuation of chronic pelvic pain by repeated administration of tadalafil. Prostate. https://doi.org/10.1002/pros.23750

    Article  PubMed  Google Scholar 

  41. Pontari MA, Ruggieri MR (2008) Mechanisms in prostatitis/chronic pelvic pain syndrome (Reprinted from The Journal of Urology, vol 172, pg 839–845. J Urol 179(5):S61–S67. https://doi.org/10.1016/j.juro.2008.03.139

    Article  PubMed  Google Scholar 

  42. Penna G, Fibbi B, Maggi M, Adorini L (2009) Prostate autoimmunity: from experimental models to clinical counterparts. Expert Rev Clin Immunol 5(5):577–586. https://doi.org/10.1586/eci.09.37

    Article  CAS  PubMed  Google Scholar 

  43. Doble A, Thomas BJ, Walker MM, Harris JR, Witherow RO, Taylor-Robinson D (1989) The role of Chlamydia trachomatis in chronic abacterial prostatitis: a study using ultrasound guided biopsy. J Urol 141(2):332–333. https://doi.org/10.1016/s0022-5347(17)40758-0

    Article  CAS  PubMed  Google Scholar 

  44. True LD, Berger RE, Rothman I, Ross SO, Krieger JN (1999) Prostate histopathology and the chronic prostatitis/chronic pelvic pain syndrome: a prospective biopsy study. J Urol 162(6):2014–2018. https://doi.org/10.1016/s0022-5347(05)68090-1

    Article  CAS  PubMed  Google Scholar 

  45. Dikov D, Bachurska S, Staikov D, Sarafian V (2015) Intraepithelial lymphocytes in relation to NIH category IV prostatitis in autopsy prostate. Prostate 75(10):1074–1084. https://doi.org/10.1002/pros.22991

    Article  CAS  PubMed  Google Scholar 

  46. Nickel JC, Freedland SJ, Castro-Santamaria R, Moreira DM (2017) Chronic prostate inflammation predicts symptom progression in patients with chronic prostatitis/chronic pelvic pain. J Urol 198(1):122–128. https://doi.org/10.1016/j.juro.2017.01.035

    Article  PubMed  Google Scholar 

  47. Liu Y, Mikrani R, Xie D, Wazir J, Shrestha S, Ullah R, Baig MMFA, Ahmed A, Srivastava PK, Thapa KB, Zhou X (2020) Chronic prostatitis/chronic pelvic pain syndrome and prostate cancer: study of immune cells and cytokines. Fundam Clin Pharmacol 34(2):160–172. https://doi.org/10.1111/fcp.12517

    Article  CAS  PubMed  Google Scholar 

  48. Wong L, Done JD, Schaeffer AJ, Thumbikat P (2015) Experimental autoimmune prostatitis induces microglial activation in the spinal cord. Prostate 75(1):50–59. https://doi.org/10.1002/pros.22891

    Article  CAS  PubMed  Google Scholar 

  49. Keetch DW, Humphrey P, Ratliff TL (1994) Development of a mouse model for nonbacterial prostatitis. J Urol 152(1):247–250. https://doi.org/10.1016/s0022-5347(17)32871-9

    Article  CAS  PubMed  Google Scholar 

  50. Breser ML, Motrich RD, Sanchez LR, Mackern-Oberti JP, Rivero VE (2013) Expression of CXCR3 on specific T cells is essential for homing to the prostate gland in an experimental model of chronic prostatitis/chronic pelvic pain syndrome. J Immunol 190(7):3121–3133. https://doi.org/10.4049/jimmunol.1202482

    Article  CAS  PubMed  Google Scholar 

  51. Breser ML, Lino AC, Motrich RD, Godoy GJ, Demengeot J, Rivero VE (2016) Regulatory T cells control strain specific resistance to experimental autoimmune prostatitis. Sci Rep. https://doi.org/10.1038/srep33097

    Article  PubMed  PubMed Central  Google Scholar 

  52. Liu KJ, Chatta GS, Twardzik DR, Vedvick TS, True LD, Spies AG, Cheever MA (1997) Identification of rat prostatic steroid-binding protein as a target antigen of experimental autoimmune prostatitis: implications for prostate cancer therapy. J Immunol 159(1):472–480

    CAS  PubMed  Google Scholar 

  53. Liu Y, Tang M, Zhang Q, Li C, Lv R, Min H, Zhou X (2020) T2 peptide represents a major autoantigen epitope in experimental autoimmune prostatitis. Inflammation. https://doi.org/10.1007/s10753-020-01326-6

    Article  PubMed  PubMed Central  Google Scholar 

  54. Hu C, Yang HL, Zhao YF, Chen X, Dong YY, Li L, Dong YH, Cui JF, Zhu TY, Zheng P, Lin CS, Dai JC (2016) The role of inflammatory cytokines and ERK1/2 signaling in chronic prostatitis/chronic pelvic pain syndrome with related mental health disorders. Sci Rep. https://doi.org/10.1038/srep28608

    Article  PubMed  PubMed Central  Google Scholar 

  55. Zhou XH, Li LD, Wu LM, Han L, Liu ZD, Yang JX, Lv YW, You CL, Zhou ZH (2007) Increased inflammatory factors activity in model rats with experimental autoimmune prostatitis. Arch Androl 53(2):49–52. https://doi.org/10.1080/01485010600908397

    Article  CAS  PubMed  Google Scholar 

  56. Guo H, Xu YM, Ye ZQ, Yu JH, Fu Q, Sa YL, Hu XY, Song LJ (2010) Heat-shock protein 70 expression in the seminal plasma of patients with chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome. Prostate Cancer Prostatic Dis 13(4):338–342. https://doi.org/10.1038/pcan.2010.22

    Article  CAS  PubMed  Google Scholar 

  57. Motrich RD, Maccioni M, Ponce AA, Gatti GA, Oberti JPM, Rivero VE (2006) Pathogenic consequences in semen quality of an autoimmune response against the prostate gland: from animal models to human disease. J Immunol 177(2):957–967. https://doi.org/10.4049/jimmunol.177.2.957

    Article  CAS  PubMed  Google Scholar 

  58. Motrich RD, Maccioni M, Molina R, Tissera A, Olmedo J, Riera CM, Rivero VE (2005b) Reduced semen quality in chronic prostatitis patients that have cellular autoimmune response to prostate antigens. Hum Reprod 20(9):2567–2572. https://doi.org/10.1093/humrep/dei073

    Article  PubMed  Google Scholar 

  59. Zhang M, Luo C, Cui K, Xiong T, Chen Z (2020) Chronic inflammation promotes proliferation in the prostatic stroma in rats with experimental autoimmune prostatitis: study for a novel method of inducing benign prostatic hyperplasia in a rat model. World J Urol. https://doi.org/10.1007/s00345-020-03090-6

    Article  PubMed  PubMed Central  Google Scholar 

  60. Huang T, Wang G, Hu Y, Shi H, Wang K, Yin L, Peng B (2019) Structural and functional abnormalities of penile cavernous endothelial cells result in erectile dysfunction at experimental autoimmune prostatitis rat. J Inflamm. https://doi.org/10.1186/s12950-019-0224-0

    Article  Google Scholar 

  61. Motrich RD, Mackern-Oberti JP, Maccioni M, Rivero VE (2009) Effects of autoimmunity to the prostate on the fertility of the male rat. Fertil Steril 91(5):2273–2280. https://doi.org/10.1016/j.fertnstert.2008.06.046

    Article  PubMed  Google Scholar 

  62. Pacheco-Rupil B, Depiante-Depaoli M, Romero O, Romero M, Yantorno C (1981) Experimental autoimmune damage to rat male accessory glands (MAG)*. Am J Reprod Immunol 1(5):255–261. https://doi.org/10.1111/j.1600-0897.1981.tb00050.x

    Article  Google Scholar 

  63. Donadio AC, DepianteDepaoli M (1997) Inflammatory cells and MHC class II antigens expression in prostate during time-course experimental autoimmune prostatitis development. Clin Immunol Immunopathol 85(2):158–165. https://doi.org/10.1006/clin.1997.4427

    Article  CAS  PubMed  Google Scholar 

  64. Donadio AC, Gagliano H, Remedi MM, Nowotny E, Depiante-Depaoli M (1998) Time-course study of cellular immune response and testosterone metabolism in an autoimmune model for chronic prostatic inflammation. J Urol 160(4):1546–1550. https://doi.org/10.1016/s0022-5347(01)62610-7

    Article  CAS  PubMed  Google Scholar 

  65. Orsilles MA, Donadio AC, Depiantedepaoli M (1995) Time-course of reactive oxygen intermediates release and histopathological findings during experimental autoimmune prostatitis development. Prostate 27(1):50–57. https://doi.org/10.1002/pros.2990270109

    Article  CAS  PubMed  Google Scholar 

  66. Diserio GP, Nowotny E (1998) Experimental autoimmune prostatitis: in vivo induction of the autoimmune response to lymphocytic soluble factors. Alterations at the endocrine metabolism level. Am J Reprod Immunol 39(4):226–234

    Article  CAS  Google Scholar 

  67. Maccioni M, Rivero VE, Riera CM (1998) Prostatein (or rat prostatic steroid binding protein) is a major autoantigen in experimental autoimmune prostatitis. Clin Exp Immunol 112(2):159–165

    Article  CAS  Google Scholar 

  68. Rivero VE, Iribarren P, Riera CM (1995) Mast cells in accessory glands of experimentally induced prostatitis in male Wistar rats. Clin Immunol Immunopathol 74(3):236–242. https://doi.org/10.1006/clin.1995.1035

    Article  CAS  PubMed  Google Scholar 

  69. Galmarini M, Ferro ME, Riera CM (1988) Delayed hypersensitivity and lesions following isoimmunization with modified rat male accessory glands: kinetics of induction. J Reprod Immunol 13(2):147–157. https://doi.org/10.1016/0165-0378(88)90058-7

    Article  CAS  PubMed  Google Scholar 

  70. Du HX, Chen XG, Zhang L, Liu Y, Zhan CS, Chen J, Wang H, Yu ZQ, Liang CZ (2020) Experimental autoimmune prostatitis induces learning-memory impairment and structural neuroplastic changes in mice. Cell Mol Neurobiol 40(1):99–111. https://doi.org/10.1007/s10571-019-00723-2

    Article  PubMed  Google Scholar 

  71. Klyushnenkova EN, Kouiavskaia DV, Kodak JA, Vandenbark AA, Alexander RB (2007) Identification of HLA-DRB1*1501-restricted T-cell epitopes from human prostatic acid phosphatase. Prostate 67(10):1019–1028. https://doi.org/10.1002/pros.20575

    Article  CAS  PubMed  Google Scholar 

  72. Motrich RD, Breser ML, Molina RI, Tissera A, Olmedo JJ, Rivero VE (2020) Chronic prostatitis/chronic pelvic pain syndrome patients show Th1 and Th17 self-reactive immune responses specific to prostate and seminal antigens and decreased semen quality. BJU Int. https://doi.org/10.1111/bju.15117

    Article  PubMed  Google Scholar 

  73. Liu Y, Mikrani R, He Y, Baig MMFA, Abbas M, Naveed M, Tang M, Zhang Q, Li C, Zhou X (2020) TRPM8 channels: a review of distribution and clinical role. Eur J Pharmacol. https://doi.org/10.1016/j.ejphar.2020.173312

    Article  PubMed  PubMed Central  Google Scholar 

  74. Wang W, Naveed M, Majeed F, Cui X, Ihsan AU, Liu Z, Zubair HM, Tang M, Sohail M, Xiaohui Z (2019) Morphological research on expression of inflammatory mediators in murine models of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) induced by T2 antigen. Andrologia 51(11):e13435. https://doi.org/10.1111/and.13435

    Article  PubMed  Google Scholar 

  75. Zhang L, Ihsan AU, Cao Y, Cheng Y, Zhou X (2018) Establishment of experimental autoimmune prostatitis model by T-2 peptide in aluminium hydroxide adjuvant. Andrologia. https://doi.org/10.1111/and.12922

    Article  PubMed  Google Scholar 

  76. Ihsan AU, Khan FU, Nawaz W, Khan MZ, Yang MQ, Zhou XH (2017) Establishment of a rat model of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) induced by immunization with a novel peptide T2. Biomed Pharmacother 91:687–692. https://doi.org/10.1016/j.biopha.2017.05.004

    Article  CAS  PubMed  Google Scholar 

  77. Khan FU, Ihsan AU, Nawaz W, Khan MZ, Yang MQ, Wang G, Liao XQ, Han L, Zhou XH (2017) A novel mouse model of chronic prostatitis/chronic pelvic pain syndrome induced by immunization of special peptide fragment with aluminum hydroxide adjuvant. Immunol Lett 187:61–67. https://doi.org/10.1016/j.imlet.2017.05.008

    Article  CAS  PubMed  Google Scholar 

  78. Tang M, Ullah R, Wazir J, Khan FU, Ihsan AU, Cui X, Wang W, Hu M, Liu Y, Zhou X (2019) Effect of oral T2 antigen on chronic prostatitis/chronic pelvic pain syndrome in mice model. Inflammation 42:2086–2094. https://doi.org/10.1007/s10753-019-01072-4

    Article  CAS  PubMed  Google Scholar 

  79. Cheng Y, Cao Y, Ihsan AU, Khan FU, Li X, Xie D, Cui X, Wang W, Liu Z, Li C, Ahmad KA, Sembatya KR, Mikrani R, Zhou X (2019) Novel treatment of experimental autoimmune prostatitis by nanoparticle-conjugated autoantigen peptide T2. Inflammation 42(3):1071–1081. https://doi.org/10.1007/s10753-019-00968-5

    Article  CAS  PubMed  Google Scholar 

  80. Cao Y, Cheng Y, Ihsan AU, Khan FU, Xie D, Cui X, Wang W, Zhou X (2019) A nanoparticle-coupled T2 peptide induces immune tolerance and ameliorates chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in mice model. Fundam Clin Pharmacol 33(3):267–276. https://doi.org/10.1111/fcp.12438

    Article  CAS  PubMed  Google Scholar 

  81. Serra P, Santamaria P (2019) Antigen-specific therapeutic approaches for autoimmunity. Nat Biotechnol 37(3):238–251. https://doi.org/10.1038/s41587-019-0015-4

    Article  CAS  PubMed  Google Scholar 

  82. Getts DR, Martin AJ, McCarthy DP, Terry RL, Hunter ZN, Yap WT, Getts MT, Pleiss M, Luo X, King NJC, Shea LD, Miller SD (2012) Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nat Biotechnol 30(12):1217. https://doi.org/10.1038/nbt.2434

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Rivero VE, Cailleau C, Depiante-Depaoli M, Riera CM, Carnaud C (1998) Non-obese diabetic (NOD) mice are genetically susceptible to experimental autoimmune prostatitis (EAP). J Autoimmun 11(6):603–610. https://doi.org/10.1006/jaut.1998.0248

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

YL: designed the study, collected data, wrote and revised the manuscript; JW: prepared, reviewed and revised the manuscript; MT: and RU: assisted the work, reviewed and edited the manuscript; YC and TC: helped collect the data; XZ: have provided supervision, project administration and expert opinions about the study.

Corresponding author

Correspondence to Xiaohui Zhou.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, Y., Wazir, J., Tang, M. et al. Experimental autoimmune prostatitis: different antigens induction and antigen-specific therapy. Int Urol Nephrol 53, 607–618 (2021). https://doi.org/10.1007/s11255-020-02703-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-020-02703-8

Keywords

Navigation